However, there are no talks currently taking place that involve AstraZeneca being taken over by Pfizer. The news that AstraZeneca is in talks with Pfizer comes from a Reuters report that mentions talks from a month ago. During these talks, AstraZeneca rejected a takeover by Pfizer. Headlines referring to the story have been misleading and have lead some to believe that a takeover was currently being negotiated, reports NASDAQ.
“We anticipate Pfizer to push aggressively ahead with a second approach,” Andrew Baum, a Citi analyst, told Fox Business while talking about an AstraZeneca takeover.
Despite misleading news regarding an AstraZeneca takeover by Pfizer, AZN shares were up 5% as of midday Monday.
PFE shares were up 1% as of midday Monday
More Drug Stock News
- GSK Stock Down Over Poor Cancer Drug Results
- DNDN: Dendreon Surges Double Digits Following Prostate Drug News
- Purdue’s Pill Success Is Bad News for Zogenix Zohydro, ZGNX Stock